Clinical Science. Real-World Glucose Control.
INFINIS Glucose is a clinically informed glucose and metabolic support formula designed to reduce post-meal glucose and insulin exposure while supporting long-term insulin sensitivity and metabolic health through daily use.
What to Expect with gLUCOSE
Glucose is designed to work both acutely and progressively, supporting immediate post-meal glucose control first, followed by improvements in insulin efficiency and fasting glycemic markers with consistent daily use. Individual results may vary based on diet, carbohydrate intake, and consistency.
DAYS 1–7
POST-MEAL GLUCOSE CONTROL
- Reduced post-meal blood glucose spikes when taken before meals.
- Lower insulin response following carbohydrate intake.
- Smoother post-meal energy with fewer spikes and crashes.
- improved metabolic stability after eating
This phase reflects acute effects observed within 120 minutes of meals in human clinical studies.
WEEKS 2–4
INSULIN EFFICIENCY & METABOLIC RESPONSE
- More consistent post-meal glucose handling across meals.
- Reduced insulin demand following carbohydrates.
- Improved insulin signaling and metabolic efficiency.
- Better tolerance to carbohydrate-containing meals
As insulin and glucose signaling pathways adapt, responses become more predictable and stable.
Week 5-8
FASTING GLUCOSE & GLYCEMIC MARKERS
- Support for healthier fasting blood glucose levels.
- Early improvements in HbA1c and long-term glycemic balance.
- Lower fasting insulin levels, supporting insulin sensitivity.
- Reduced metabolic strain between meals
This phase aligns with 8–12 week clinical data on fasting glucose, HbA1c, and fasting insulin.
POWERED BY SCIENCE. THE HIGHEST QUALITY INGREDIENTS.
Dihydroberberine is a bioavailability-enhanced form of berberine shown to deliver higher systemic exposure than standard berberine at lower doses. It supports AMPK activation and metabolic signaling pathways involved in glucose handling and insulin efficiency.
Reducose® is a clinically studied mulberry leaf extract standardized for 1-deoxynojirimycin (DNJ), an alpha-glucosidase inhibitor that slows carbohydrate breakdown. Human trials show it reduces post-meal glucose and insulin exposure and supports healthier fasting glycemic markers with consistent use.
Ellagic acid exhibits antioxidant and anti-inflammatory activity and has been studied for its role in metabolic and insulin-resistance pathways. EA-613™ is engineered for enhanced solubility and bioavailability, supporting long-term metabolic resilience and cellular health.
R-alpha lipoic acid is a biologically active antioxidant involved in mitochondrial energy metabolism and glucose uptake. The stabilized sodium form improves stability and absorption, supporting insulin sensitivity and cellular metabolic efficiency.
Bitter melon contains bioactive compounds that support cellular glucose uptake and insulin-like activity. Human and mechanistic studies suggest it helps support healthy blood sugar metabolism and insulin signaling.
Cinnamon polyphenols have been shown to support insulin receptor activity and glucose transport at the cellular level. Clinical studies associate cinnamon extract with improved insulin sensitivity and healthier fasting glucose markers.
Everything You Need to Know About GLUCOSE
INFINIS Glucose is designed for individuals who want a research-grade daily foundation to support post-meal glucose control, insulin efficiency, and long-term metabolic health.
- Individuals looking to better manage post-meal blood sugar responses, especially around carbohydrate-containing meals.
- Those seeking improved insulin sensitivity and metabolic efficiency with consistent daily use.
- Anyone focused on supporting healthier fasting glucose and long-term glycemic markers such as HbA1c.
- Athletes and active individuals who want better carbohydrate utilization, nutrient partitioning, and metabolic resilience.
- Individuals following higher-carbohydrate diets who want smoother energy and fewer post-meal spikes and crashes.
- Anyone looking for a daily glucose support supplement that works both acutely with meals and chronically over time.
INFINIS Glucose is more than a basic blood sugar supplement — it’s a research-grade metabolic foundation built with clinically studied bioactive compounds designed to support post-meal glucose control, insulin efficiency, and long-term metabolic health.
Designed for daily use, not just occasional carbohydrate “blocking,” INFINIS Glucose supports the core biological pathways that regulate glucose metabolism and insulin signaling. It’s formulated for individuals who care about durable metabolic health and consistency, not short-term suppression or stimulatory effects.
What sets it apart:
- Multi-Pathway Glucose Support: Combines carbohydrate digestion modulation, insulin signaling support, and cellular glucose utilization.
- Clinically Studied Ingredients: Built around human research, including the clinically validated effects of Reducose® on post-meal glucose and insulin exposure.
- Acute + Chronic Design: Works immediately around meals and compounds benefits over weeks with consistent daily use.
- Metabolic Health Focus: Supports fasting glucose, HbA1c, and insulin sensitivity as part of long-term metabolic efficiency.
- Meal-Flexible Timing: Designed to be taken with carbohydrate-containing meals — no rigid protocols or cycling required.
- Clean, Transparent Formula: Fully disclosed dosages using standardized, high-purity ingredients.
- Clinically Studied Glucose Control: Built around human clinical data, including the validated post-meal glucose and insulin–lowering effects of Reducose®.
- Multi-Pathway Metabolic Design: Targets carbohydrate digestion, insulin signaling, and cellular glucose utilization rather than relying on a single mechanism.
- Acute + Long-Term Action: Designed to work immediately with meals while supporting fasting glucose, HbA1c, and insulin sensitivity over weeks of daily use.
- Metabolic Health–First Formulation: Focuses on insulin efficiency and metabolic resilience, not stimulatory effects or aggressive carbohydrate blocking.
- Built for Daily Use: Intended to be used consistently with carbohydrate-containing meals as a foundational metabolic support, not a short-term intervention.
INFINIS Glucose is designed to be taken with carbohydrate-containing meals to support post-meal glucose and insulin control. For best results, take one capsule with each main carbohydrate-containing meal, up to three times daily, as part of your regular eating routine.
It does not require workout timing and can be used on training days and rest days alike. Consistent daily use supports both immediate post-meal benefits and longer-term improvements in metabolic and glycemic markers.
INFINIS Glucose works both acutely and progressively, with results depending on dietary carbohydrate intake, consistency, and individual metabolic response.
- Within the first few days to 1 week, many users notice smaller post-meal glucose spikes, smoother energy after eating, and reduced post-meal crashes when taken with carbohydrate-containing meals. These effects reflect the acute, meal-based action observed in human clinical research.
- By weeks 2–4, post-meal glucose and insulin responses often become more consistent across meals, with improved tolerance to carbohydrates and reduced insulin demand. During this phase, users may notice steadier day-to-day energy and improved metabolic stability.
- By weeks 5–8, consistent daily use may support healthier fasting glucose, lower fasting insulin, and early improvements in long-term glycemic markers such as HbA1c, reflecting improvements in insulin sensitivity and baseline metabolic control.
INFINIS Glucose is designed for daily, long-term use, supporting durable metabolic health rather than short-term glucose suppression.
